Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Yuryev

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Discovery|October 14, 2014
Gene expression profiling for targeted cancer treatmentAnton Yuryev
Expert Opinion on Drug Discovery|June 5, 2012
Contextual data integration in drug discoveryAnton Yuryev
Expert Opinion on Therapeutic Targets|May 19, 2006
Targeting transcription factors in cell regulationAnton Yuryev
Expert Opinion on Drug Discovery|March 15, 2013
In silico pathway analysis: the final frontier towards completely rational drug designAnton Yuryev
Expert Opinion on Drug Discovery|June 1, 2012
Integrating fragmented software applications into holistic solutions: focus on drug discoveryAnton Yuryev
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2007
PCR primer design using statistical modelingAnton Yuryev
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2007
Developing a statistical model for primer designJianping Huang, Anton Yuryev
Genomics|March 7, 2003
Novel raf kinase protein-protein interactions found by an exhaustive yeast two-hybrid analysisAnton Yuryev, Lawrence P Wennogle
Expert Opinion on Therapeutic Targets|February 15, 2007
Pathway analysis software as a tool for drug target selection, prioritization and validation of drug mechanismAndrey Y Sivachenko, Anton Yuryev
Expert Opinion on Drug Discovery|March 14, 2013
Ariadne's ChemEffect and Pathway Studio knowledge baseAnton Yuryev, Ekaterina Kotelnikova, Nikolai Daraselia
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Discovery|October 14, 2014
Gene expression profiling for targeted cancer treatmentAnton Yuryev
Expert Opinion on Drug Discovery|June 5, 2012
Contextual data integration in drug discoveryAnton Yuryev
Expert Opinion on Therapeutic Targets|May 19, 2006
Targeting transcription factors in cell regulationAnton Yuryev
Expert Opinion on Drug Discovery|March 15, 2013
In silico pathway analysis: the final frontier towards completely rational drug designAnton Yuryev
Expert Opinion on Drug Discovery|June 1, 2012
Integrating fragmented software applications into holistic solutions: focus on drug discoveryAnton Yuryev
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2007
PCR primer design using statistical modelingAnton Yuryev
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2007
Developing a statistical model for primer designJianping Huang, Anton Yuryev
Genomics|March 7, 2003
Novel raf kinase protein-protein interactions found by an exhaustive yeast two-hybrid analysisAnton Yuryev, Lawrence P Wennogle
Expert Opinion on Therapeutic Targets|February 15, 2007
Pathway analysis software as a tool for drug target selection, prioritization and validation of drug mechanismAndrey Y Sivachenko, Anton Yuryev
Expert Opinion on Drug Discovery|March 14, 2013
Ariadne's ChemEffect and Pathway Studio knowledge baseAnton Yuryev, Ekaterina Kotelnikova, Nikolai Daraselia
Pageof 4